Dana-Farber President and CEO Edward J. Benz, Jr, MD, to Retire in 2016

Get Permission

Edward J. Benz, Jr, MD

Dana-Farber President and CEO Edward J. Benz, Jr, MD, has announced he will retire from the Dana-Farber Cancer Institute (DFCI) in 2016, after 16 years running the organization.

Dr. Benz will also vacate the positions as Director and Principal Investigator of the Dana-Farber/Harvard Cancer Center and Trustee of Dana-Farber/Children’s Hospital Cancer Care.

He will remain Professor of Medicine, Pediatrics, and Genetics at Harvard Medical School and will focus full-time on his research.

Under Dr. Benz’s leadership, Dana-Farber has tripled in size. Annual giving has grown from $50 million to $200 million, and revenue has tripled to roughly $1.1 billion. Dana-Farber’s workforce and patient volume have also tripled in the interim. ■





By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.